Group 3B: Novel Therapeutic, Triple Negative Breast Cancer

Thursday, Sept 15
6:00 pm – 7:30 pm Eastern Time (US/New York)

Poster #1: 

The RNA Helicase Eif4a Is a Therapeutic Vulnerability In Metastatic Triple-Negative Breast Cancer

Poster #2:

Combinatorial Chemo- and CSF-1R Antibody Targeted Therapy for the Treatment of Metastatic Triple Negative Breast Cancer

Poster author Diego Pedroza, Ph.D. may attend this session

Mentor: Denise Smith

Denise Smith has Bachelor’s degrees in Nursing and Microbiology. As well as is a recent graduate of the NBCC Project LEAD program. Over the last three years Denise has participated as an advocate reviewer for the Department of Defense  congressionally directed research program for Breast Cancer. She currently spends time serving on the Breast & Gynecologic Cancers Research Advocate (BGCRA) committee under  the direction of Dr. Alana Welm. Denise also recently had the opportunity of representing Metastatic Breast Cancer (MBC) patients during the NBCC Lobby Day in Washington, D.C. As an MBC patient herself, she truly enjoys advocacy and sharing her experiences to help move research forward in finding a cure.

Scientist: Carmen J. Calfa, M.D.

Dr. Calfa is a triple board-certified breast medical oncologist and has been recognized for her clinical care and research. She is an assistant professor of clinical medicine at the University of Miami Miller School of Medicine. At Sylvester, Dr. Calfa works as part of a multidisciplinary team of breast cancer experts and researchers. She earned her medical degree from the University of Medicine and Pharmacy of Tirgu-Mures in Romania.

Twitter: @CarmenCalfa